Needham & Company
View Older Stories
-
Mighty Therapeutics Partners with the POLG Foundation to Develop Novel Preclinical Model for POLG Mitochondrial Disorders and Parkinson's Disease
-
5 stocks to buy as AI's memory problem has turned into a networking problem
-
Two Powerhouses, One Drive: SharkNinja Joins McLaren Racing as Official Partner
-
The Elmet Group (ELMT) PT Raised to $25 at Needham
-
Eos Energy Enterprises (EOSE) PT Lowered to $10 at Needham
-
Symbotic Inc. (SYM) PT Lowered to $60 at Needham
-
Teledyne (TDY) PT Raised to $760 at Needham
-
Zebra Technologies (ZBRA) PT Raised to $435 at Needham
-
Solaris Energy Infrastructure (SEI) PT Raised to $104 at Needham
-
Needham Reiterates Buy Rating on Veracyte, Inc (VCYT)
-
Tripadvisor Announces 2026 Travelers' Choice Awards: Best of the Best Restaurants, Showcasing the World's Top Eateries & Experiences
-
SharkNinja Honored in the Fast Company 2026 Innovation by Design Awards
-
Needham Starts GSI Technology (GSIT) at Buy
-
Needham Starts Inflarx NV (IFRX) at Buy
-
Needham Downgrades ACV Auctions Inc (ACVA) to Hold
-
ServiceNow (NOW) PT Raised to $155 at Needham
-
Needham Starts Next Vision Stabilized Systems (NXSN:IT) at Buy
-
Needham Reiterates Buy Rating on TransMedics Group (TMDX)
-
Needham Reiterates Buy Rating on Nu Holdings (Nubank) (NU)
-
Ninja Launches New Nonstick Ceramic-Coated Cookware That Won’t Quit On You
-
Candel Therapeutics adds regulatory veteran to its board
-
Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
-
Analysts split on Apple after foldable iPhone Duo debut
-
Cooper Companies (COO) PT Lowered to $73 at Needham
-
Needham Reiterates Buy Rating on Navan Inc (NAVN)
-
Needham Reiterates Buy Rating on Klaviyo Inc (KVYO)
-
Needham on Chewy Inc. (CHWY): 'Growth Concerns Remain'
-
Needham on Barnes & Noble Education (BNED): 'we remain buyers on the weakness'
-
Mighty Therapeutics Initiates IND-Enabling Studies of MYTX-255: a Mitochondrial-Targeted Therapeutic Candidate
-
Varonis Systems (VRNS) PT Raised to $55 at Needham
-
Needham Starts Kodiak AI (KDK) at Buy
-
Needham Reiterates Buy Rating on ServiceTitan (TTAN)
-
Needham Reiterates Buy Rating on Braze Inc (BRZE)
-
Needham Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
Lantronix CEO to Participate in Upcoming Investor and Industry Events
-
Formation Metals Extends A-Zone 200 Metres to the South and Identifies a New Vein Set, Returning 2.53 g/t Au over 11.8 Metres and 1.41 g/t Au over 20.6 Metres at the Advanced N2 Property
-
Needham Starts Securitize Corp (SECZ) at Buy
-
Planet Labs (PL) PT Lowered to $40 at Needham
-
Zscaler (ZS) PT Raised to $215 at Needham
-
Needham Reiterates Buy Rating on NVIDIA (NVDA)
-
Needham Reiterates Buy Rating on Ambarella (AMBA)
-
Needham on Docusign Inc. (DOCU): 'warming up to the consistent execution & improving KPIs'
-
Needham on Lululemon (LULU): 'Numbers Moving Down Once Again As Visibility Remains Low'
-
ŌURA Files Registration Statement for Proposed Initial Public Offering
-
CIENA (CIEN) PT Lowered to $520 at Needham, 'We would be buyers on weakness'
-
Magnite (MGNI) PT Raised to $30 at Needham
-
Snowflake Inc. (SNOW) PT Raised to $450 at Needham
-
UiPath Inc. (PATH) PT Raised to $22 at Needham
-
Needham on c3.ai (AI): 'Turnaround Remains On-Track'
-
Needham Reiterates Buy Rating on Klaviyo Inc (KVYO)

